Here’s Why Zoetis (ZTS) Is one of the Best Wide Moat Stocks to Buy According to Wall Street Analysts

The institution saw gross of $2.3 cardinal successful Q1 2026, implying an summation of 3% YoY and level connected an integrated operational basis. The gross successful the U.S. conception amounted to $1.1 billion, demonstrating a diminution of 8% connected a reported and integrated operational ground compared to Q1 2025, with companion carnal merchandise income falling 11% due to the fact that of softer end-market request and competitory landscape.

For FY 2026, Zoetis Inc. (NYSE:ZTS) expects gross of betwixt $9.680 cardinal – $9.960 cardinal (organic operational maturation of 2% – 5%), portion adjusted nett income is anticipated betwixt $2.870 cardinal and $2.950 cardinal (organic operational maturation of 2% – 6%).

Zoetis Inc. (NYSE:ZTS) is simply a starring carnal wellness company, and it discovers, develops, manufactures, and commercializes vaccines, medicines, diagnostics, biopharmaceuticals, and integer solutions for companion animals and livestock.

While we admit the imaginable of ZTS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best FMCG Stocks to Invest In According to Analysts and 11 Best Long-Term Tech Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey connected Google News.